US FDA approves Outlook Therapeutics' eye disease drug
OTLK•FDA approves Outlook Therapeutics' eye disease drug
July 24 (Reuters) - The U.S. Food and Drug Administration on Friday approved Outlook Therapeutics' OTLK.O drug for a type of eye disease that can cause severe vision loss, the company said.
